T-knife

Biotechnology

Founded in 1/1/18

Berlin, Berlin, Germany

http://www.t-knife.com/

For Profit

About T-knife

T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.

Company Metrics

Employees: 101-250
Monthly Visits: 550
Tech Stack: None active products

Financial Information

Estimated Revenue: $1M to $10M
Total Funding: 197435084 USD
Last Funding: 110000000 USD (Series B)
Funding Status: Early Stage Venture

Technology Stack

T-knife actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology

Headquarters: Berlin, Berlin, Germany

Leadership

Elisa Kieback - CTO and co-founder LinkedIn
Megan Baierlein - Senior Vice President and Chief Operating Officer LinkedIn

Employees

Tom Soloway - Chief Executive Officer (LinkedIn)